Richard E. Uihlein is Director & 10% Owner at GALECTIN THERAPEUTICS INC (GALT). They have made 5 open-market trades across 1 company since 2019, most recently 2026-07-31.
CIK 0001694903
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $40.6M since 2019, never a sale. Across 5 scored buys the stock is down 15.0% at ninety days, and 20.6 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| GALT | 44,713,843 | $162.8M |
Shares reported on the most recent Form 4, priced at the 2026-08-04 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 20% | 0% |
| Avg Move | -11.0% | -3.1% | -15.0% |
| Alpha | -11.7% | -5.6% | -20.6% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GALT | BUY | 2020-09-04 | 2020-09-09 | $2.55 | $26K | -8.2% | -5.8% | -8.2% |
| GALT | BUY | 2019-05-31 | 2019-06-03 | $4.28 | $40.0M | -11.0% | -3.2% | -21.6% |
| GALT | BUY | 2019-04-09 | 2019-04-09 | $4.82 | $100K | -15.1% | -8.6% | -17.3% |
| GALT | BUY | 2019-04-05 | 2019-04-08 | $4.81 | $202K | -12.1% | -5.7% | -17.2% |
| GALT | BUY | 2019-01-28 | 2019-01-31 | $4.86 | $251K | -8.6% | +7.6% | -10.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.